Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This protocol is evaluating efficacy and toxicity of three sequential whole bladder
photodynamic treatment with Photofrin and red laser light (630 nm) in the management of
superficial bladder cancer (non-muscle invasive) in those patients who have failed or are not
candidates for conventional intravesical therapy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
North Florida/South Georgia Veterans Health System
Collaborators:
Axcan Pharma North Florida Foundation for Research and Education